These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 6305312)

  • 1. A low thymidine kinase-producing mutant of herpes simplex virus type 1 causes latent trigeminal ganglia infections in mice.
    Gordon Y; Gilden DH; Shtram Y; Asher Y; Tabor E; Wellish M; Devlin M; Snipper D; Hadar J; Becker Y
    Arch Virol; 1983; 76(1):39-49. PubMed ID: 6305312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurovirulence of herpes simplex virus type 1 depends on age in mice and thymidine kinase expression.
    Ben-Hur T; Hadar J; Shtram Y; Gilden DH; Becker Y
    Arch Virol; 1983; 78(3-4):303-8. PubMed ID: 6318700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus after in vivo complementation.
    Tenser RB; Edris WA
    J Virol; 1987 Jul; 61(7):2171-4. PubMed ID: 3035217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication, latent infection, and reactivation in neuronal culture with a herpes simplex virus thymidine kinase-negative mutant.
    Wilcox CL; Crnic LS; Pizer LI
    Virology; 1992 Mar; 187(1):348-52. PubMed ID: 1310559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and latent infection by thymidine kinase mutants of herpes simplex virus type 2.
    Tenser RB; Jones JC; Ressel SJ
    J Infect Dis; 1985 Mar; 151(3):548-50. PubMed ID: 2982968
    [No Abstract]   [Full Text] [Related]  

  • 6. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
    Coen DM; Irmiere AF; Jacobson JG; Kerns KM
    Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppression promotes ocular virus replication and CNS neurovirulence following corneal inoculation with an avirulent herpes simplex type 1 thymidine kinase negative mutant.
    Gordon YJ; Rao H; Arullo-Cruz T
    Curr Eye Res; 1984 Apr; 3(4):651-7. PubMed ID: 6325093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.
    Coen DM; Kosz-Vnenchak M; Jacobson JG; Leib DA; Bogard CL; Schaffer PA; Tyler KL; Knipe DM
    Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4736-40. PubMed ID: 2543985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-cultivation versus blot hybridization for the detection of trigeminal ganglionic latency following corneal inoculation with HSV-1 strains of varying TK expression and pathogenicity.
    Gordon YJ; Rock DL
    Curr Eye Res; 1984 Sep; 3(9):1097-100. PubMed ID: 6092001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus.
    Tenser RB; Miller RL; Rapp F
    Science; 1979 Aug; 205(4409):915-7. PubMed ID: 224454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus thymidine kinase expression in infection of the trigeminal ganglion.
    Tenser RB; Dunstan ME
    Virology; 1979 Dec; 99(2):417-22. PubMed ID: 229629
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of latent thymidine kinase-deficient herpes simplex virus in trigeminal ganglia of mice using the polymerase chain reaction.
    Friedrich A; Kleim JP; Schneweis KE
    Arch Virol; 1990; 113(1-2):107-13. PubMed ID: 2167055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A herpes simplex virus type 1 mutant containing a nontransinducing Vmw65 protein establishes latent infection in vivo in the absence of viral replication and reactivates efficiently from explanted trigeminal ganglia.
    Steiner I; Spivack JG; Deshmane SL; Ace CI; Preston CM; Fraser NW
    J Virol; 1990 Apr; 64(4):1630-8. PubMed ID: 2157048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenicity of ribonucleotide reductase-null mutants of herpes simplex virus type 1 in mice.
    Yamada Y; Kimura H; Morishima T; Daikoku T; Maeno K; Nishiyama Y
    J Infect Dis; 1991 Dec; 164(6):1091-7. PubMed ID: 1659596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of herpes simplex thymidine kinase expression in neurovirulence and latency in newborn vs. adult mice.
    Hay KA; Gaydos A; Tenser RB
    J Neuroimmunol; 1995 Aug; 61(1):41-52. PubMed ID: 7560011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidine Kinase-Negative Herpes Simplex Virus 1 Can Efficiently Establish Persistent Infection in Neural Tissues of Nude Mice.
    Huang CY; Yao HW; Wang LC; Shen FH; Hsu SM; Chen SH
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27974554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis.
    Efstathiou S; Kemp S; Darby G; Minson AC
    J Gen Virol; 1989 Apr; 70 ( Pt 4)():869-79. PubMed ID: 2543763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 2,2'-O-cyclocytidine and acyclovir on latent herpes simplex virus in trigeminal ganglia of mice.
    Liu WG; Chen ZJ; Song JZ; Ma ZX
    Antimicrob Agents Chemother; 1986 Feb; 29(2):278-80. PubMed ID: 2424367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal control of herpes simplex virus latency.
    Tenser RB; Edris WA; Hay KA
    Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the herpes simplex virus type 1 ribonucleotide reductase gene alters virulence and latency in vivo.
    Idowu AD; Fraser-Smith EB; Poffenberger KL; Herman RC
    Antiviral Res; 1992 Feb; 17(2):145-56. PubMed ID: 1313220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.